Joint Corp (JYNT) was Downgraded by Feltl & Co. to ” Buy”. Earlier the firm had a rating of “Strong Buy ” on the company shares. Feltl & Co. advised their investors in a research report released on Jun 24, 2016.
Joint Corp opened for trading at $2.68 and hit $2.9 on the upside on Tuesday, eventually ending the session at $2.79, with a gain of 3.72% or 0.1 points. The heightened volatility saw the trading volume jump to 16,831 shares. Company has a market cap of $35 M.
In a different news, on Jun 22, 2016, David M Orwasher (Former Chief Dev/Strat Officer) sold 600 shares at $2.80 per share price. According to the SEC, on Mar 30, 2016, Ronald V Davella (director) purchased 3,000 shares at $3.14 per share price. On Mar 28, 2016, John B Richards (CEO) purchased 3,295 shares at $2.98 per share price, according to the Form-4 filing with the securities and exchange commission.
The Joint Corp. is a franchisor and an operator of chiropractic clinics that uses a private pay non-insurance cash-based model. The Company is engaged in franchising chiropractic clinics selling regional developer rights and supporting the operations of franchised chiropractic clinics at locations throughout the United States. Its clinics offer membership and wellness packages. The Company’s patients arrive at its clinics without appointments. Once a patient has joined the Company’s system and is returning for treatment they swipe their membership card at a card reader at the reception desk to announce their arrival. The patient is then escorted to an open adjustment area where they are required to remove their outerwear to receive their adjustment. Each patient’s records are digitally updated for ready retrieval in the Company’s data storage system by its chiropractors in compliance with all applicable medical records security and privacy regulations.